🔎 Trials Near Me

Gara Jalqabaatti › Kansara Harkaa (Karsinomaa Seli Renal) › Massachusetts › Boston

Qorannoo klinikaalii Kansara Harkaa (Karsinomaa Seli Renal) Boston, MA keessatti

Qorannoo 16 Kansara Harkaa (Karsinomaa Seli Renal) f Boston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Research Site, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05536141

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Exelixis Clinical Site #7, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT05176483

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Namoota walitti qabaa jiraSadarkaa 1/2
  • Tufts Medical Center, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06047379

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Namoota walitti qabaa jiraSadarkaa 2
  • Massachusetts General Hospital Cancer Center, Boston
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT05327686

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • Brigham and Women's Hospital, Boston
  • Dana Farber/Mass General Brigham Cancer Care, Inc, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07227415

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Tufts Medical Center, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06661720

A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma

Namoota walitti qabaa jiraSadarkaa 2
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT07123090

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

Namoota walitti qabaa jiraSadarkaa 1
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT06966024

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

Namoota walitti qabaa jiraSadarkaa 1
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT07195682

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Massachusetts General Hospital, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ado-2026 · NCT03972657

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Wax-2026 · NCT06026410

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Beth Israel Deaconess Medical Center /ID# 252009, Boston
  • Dana-Farber Cancer Institute /ID# 249642, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Wax-2026 · NCT04777994

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

Namoota walitti qabaa jiraSadarkaa 2
  • Beth Israel Deaconess Medical Center, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Cam-2026 · NCT06053658

Drug Screening Using Novel IMD in Renal Cell Carcinoma

Namoota walitti qabaa jiraSadarkaa 1
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Cam-2026 · NCT05700461

Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC

Namoota walitti qabaa jiraSadarkaa 2
  • Beth Israel Deaconess Medical Center, Boston
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Bit-2026 · NCT07397611

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Namoota walitti qabaa jiraSadarkaa 1/2
  • Massachusetts General Hospital, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Sad-2024 · NCT04787042

Qorannoo Kansara Harkaa (Karsinomaa Seli Renal) magaalota biroo keessatti

Qorannoo biroo Boston keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.